Patents by Inventor Zhengbin Yao

Zhengbin Yao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
    Publication number: 20030147887
    Abstract: The present invention provides vaccines, antibodies, and diagnostic tools for the diagnosis and/or treatment of B-cell mediated diseases, particularly B-cell lymphomas.
    Type: Application
    Filed: November 2, 2002
    Publication date: August 7, 2003
    Inventors: Shen-Wu Wang, Guanghui Hu, Yucheng Li, Zhengbin Yao
  • Screening methods for altering circadian rhythms and for human casein kinase I &dgr; and/or &egr; phosphorylation of human clock proteins, period 1, -2 and -3
    Patent number: 6555328
    Abstract: The present invention is directed to methods to identify test compounds that alter circadian rhythms of mammals, and more specifically, directed to methods for determining the ability of a test compound to alter hCKI &dgr; and &egr; phosphorylation of a human Period protein. The present invention is also directed to a method for determing the ability of a test compound to selectively alter phosphorylation, interaction with, or alternatively degradation, of one or more human Period proteins relative to its ability to alter phosphorylation, interaction with, or alternatively degradation, of a different human Period protein.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: April 29, 2003
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: George A. Keesler, Cesare Mondadori, Zhengbin Yao, Fernando Camacho
  • Assay kits for detection and methods of inhibiting IL-17 binding
    Patent number: 6197525
    Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, pharmaceutical compositions made therefrom, detection assays and methods of inhibiting binding of the receports are disclosed. The isolated receptors can be used to regulate an immune response.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: March 6, 2001
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
  • Methods of treating immune and inflammatory response with IL-17 receptors
    Patent number: 6100235
    Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, and methods of treatment using the IL-17 receptors are disclosed. The isolated receptors can be used to regulate an immune response.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: August 8, 2000
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
  • Receptor that binds IL-17
    Patent number: 6096305
    Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: August 1, 2000
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
  • Antibodies to the IL-17 receptor
    Patent number: 6072037
    Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, antibodies to such receptors and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.
    Type: Grant
    Filed: February 12, 1998
    Date of Patent: June 6, 2000
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
  • Receptor that binds IL-17
    Patent number: 6072033
    Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: June 6, 2000
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
  • Receptor that binds IL-17
    Patent number: 5869286
    Abstract: Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.
    Type: Grant
    Filed: March 21, 1996
    Date of Patent: February 9, 1999
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, William C. Fanslow
  • Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules
    Patent number: 5716623
    Abstract: Isolated viral proteins, and compositions made therefrom, are disclosed which are capable of binding to Class II Major Histocompatibility Complex antigen, thereby functioning to inhibit an antigen-specific response. The isolated viral proteins also act as superantigens.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 10, 1998
    Assignee: Immunex Corporation
    Inventors: Zhengbin Yao, Melanie K. Spriggs, Mark Alderson, Richard J. Armitage